Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lage

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Scientific Reports|May 7, 2021
Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, ArgentinaA Yacobitti, L Otero, V Doldan Arrubarrena, et al.
Scientific Reports|August 28, 2021
Publisher Correction: Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, ArgentinaA Yacobitti, L Otero, V Doldan Arrubarrena, et al.
International Journal of Nanomedicine|March 15, 2014
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery systemTatiana G Ribeiro, Miguel A Chávez-Fumagalli, Diogo G Valadares, et al.
Plos Neglected Tropical Diseases|April 11, 2013
Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasisVivian T Martins, Miguel A Chávez-Fumagalli, Lourena E Costa, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Scientific Reports|May 7, 2021
Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, ArgentinaA Yacobitti, L Otero, V Doldan Arrubarrena, et al.
Scientific Reports|August 28, 2021
Publisher Correction: Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, ArgentinaA Yacobitti, L Otero, V Doldan Arrubarrena, et al.
International Journal of Nanomedicine|March 15, 2014
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery systemTatiana G Ribeiro, Miguel A Chávez-Fumagalli, Diogo G Valadares, et al.
Plos Neglected Tropical Diseases|April 11, 2013
Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasisVivian T Martins, Miguel A Chávez-Fumagalli, Lourena E Costa, et al.
Pageof 7